Source: BioPortfolio

Silvergate: CutisPharma Announces Acquisition of Silvergate Pharmaceuticals Name Change to Azurity Pharmaceuticals

CutisPharma Inc. announced today its acquisition of Silvergate Pharmaceuticals Inc. and the unveiling of its new corporate brand for the unified company Azurity Pharmaceuticals. I am thrilled to announce the combination...

Read full article »
Silvergate's Competitors | Silvergate's News | Silvergate's Financials
Stay up-to-date with the latest news on Silvergate Pharmaceuticals
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Neal I. Muni's photo - President & CEO of Silvergate Pharmaceuticals

President & CEO

Neal I. Muni

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Silvergate Pharmaceuticals